home / stock / naov / naov news


NAOV News and Press, NanoVibronix Inc. From 07/22/21

Stock Information

Company Name: NanoVibronix Inc.
Stock Symbol: NAOV
Market: NASDAQ
Website: nanovibronix.com

Menu

NAOV NAOV Quote NAOV Short NAOV News NAOV Articles NAOV Message Board
Get NAOV Alerts

News, Short Squeeze, Breakout and More Instantly...

NAOV - NanoVibronix says positive results from UroShield study published in medical journal

NanoVibronix (NAOV) announces that The Journal of Medical & Surgical Urology is publishing an article with positive findings from a study of patients that used its UroShield in real world settings.NAOV shares up 6.3% premarket at $0.85.For the study, 23 patients with reoccurring...

NAOV - NanoVibronix Announces Publication of Compelling Study Results for UroShield in The Journal of Medical & Surgical Urology

Elmsford, NY, July 22, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (“SAW”) Portable Ultrasonic Therapeutic Devices, today announced that The Jour...

NAOV - NanoVibronix Provides Business Update

ELMSFORD, N.Y., June 03, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (“SAW”) Portable Ultrasonic Therapeutic Devices, today provided an update on its...

NAOV - NanoVibronix Announces Expanded CMS Reimbursement Approval for PainShield

ELMSFORD, N.Y., April 26, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the ...

NAOV - NanoVibronix Announces Start of Real World Patient Study of UroShield

Independent Study Being Led by Southampton University Health Sciences Patient Recruitment Underway; Interim Results Expected in October 2021 NanoVibronix, Inc . , (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShie...

NAOV - Chembio Diagnostics, Nano-X Imaging leads healthcare gainers; Molecular Templates, ACADIA Pharmaceuticals among major losers

Gainers: Chembio Diagnostics CEMI +60%, Nano-X Imaging NNOX +25%, NanoVibronix (NAOV) +16%, Vivos Therapeutics (VVOS) +15%, Greenwich LifeSciences (GLSI) +14%.Losers: Molecular Templates (MTEM) -26%, ACADIA Pharmaceuticals ACAD -17%,...

NAOV - TSLA, NVTA, CHPT and NNOX among premarket gainers

Nano-X Imaging (NNOX) +68% as FDA OKs 510(k) for Single Source Nanox.ARC Digital X-Ray.Chembio Diagnostics (CEMI) +48%.NanoVibronix (NAOV) +24%.Leaf Group Ltd. (LEAF) +19% on being acquired by Graham Holdings for $8.50 per share.dMY Technology Group (DMYD) +19%.Hoth Therapeutics (HO...

NAOV - NanoVibronix Adjourns Special Meeting of Stockholders

NanoVibronix, Inc . (the “ Company ”) (NASDAQ: NAOV ) announced today that the Company’s Special Meeting of Stockholders, scheduled for 10:00 a.m. Eastern time today, March 31, 2021, has been adjourned to allow for more time for stockholders to vote. The...

NAOV - MARA, BLUE, TME and CAN among premarket gainers

Universe Pharmaceuticals (UPC) +113%.Humanigen (HGEN) +61% on positive Phase 3 data for COVID-19 therapy.Cyanotech Corporation (CYAN) +48%.Big Rock Partners Acquisition (BRPA) +42%.SeaChange International (SEAC) +34% on multi-million-dollar contract with broadband service provider.F...

NAOV - Dollar General, ZTO Express leads the premarket losers' pack

Translate Bio (TBIO) -26% after Translate Bio’s Cystic Fibrosis therapy fails to improve lung function in Phase 1/2 trial.PhaseBio Pharmaceuticals (PHAS) -14% on equity raise.Broadway Financial (BYFC) -13% after stockholders of Broadway Financial and CFBan...

Previous 10 Next 10